SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Volodymyr Dzhala, Kevin J. Staley, Acute and Chronic Efficacy of Bumetanide in an in vitro Model of Posttraumatic Epileptogenesis, CNS Neuroscience & Therapeutics, 2015, 21, 2
  2. 2
    Gregory L. Holmes, Chengju Tian, Amanda E. Hernan, Sean Flynn, Devon Camp, Jeremy Barry, Alterations in sociability and functional brain connectivity caused by early-life seizures are prevented by bumetanide, Neurobiology of Disease, 2015, 77, 204

    CrossRef

  3. 3
    Kathrin Töllner, Claudia Brandt, Thomas Erker, Wolfgang Löscher, Bumetanide is not capable of terminating status epilepticus but enhances phenobarbital efficacy in different rat models, European Journal of Pharmacology, 2015, 746, 78

    CrossRef

  4. 4
    Roustem Khazipov, Guzel Valeeva, Ilgam Khalilov, Depolarizing GABA and Developmental Epilepsies, CNS Neuroscience & Therapeutics, 2015, 21, 2
  5. 5
    Maria D. Donovan, Fionn E. O'Brien, Geraldine B. Boylan, John F. Cryan, Brendan T. Griffin, The effect of organic anion transporter 3 inhibitor probenecid on bumetanide levels in the brain: an integrated in vivo microdialysis study in the rat, Journal of Pharmacy and Pharmacology, 2015, 67, 4
  6. 6
    Kathrin Töllner, Claudia Brandt, Kerstin Römermann, Wolfgang Löscher, The organic anion transport inhibitor probenecid increases brain concentrations of the NKCC1 inhibitor bumetanide, European Journal of Pharmacology, 2015, 746, 167

    CrossRef

  7. 7
    Kai Kaila, Theodore J. Price, John A. Payne, Martin Puskarjov, Juha Voipio, Cation-chloride cotransporters in neuronal development, plasticity and disease, Nature Reviews Neuroscience, 2014, 15, 10, 637

    CrossRef

  8. 8
    Gabriele Deidda, Ignacio F. Bozarth, Laura Cancedda, Modulation of GABAergic transmission in development and neurodevelopmental disorders: investigating physiology and pathology to gain therapeutic perspectives, Frontiers in Cellular Neuroscience, 2014, 8,

    CrossRef

  9. 9
    Martin Puskarjov, Kristopher T. Kahle, Eva Ruusuvuori, Kai Kaila, Pharmacotherapeutic targeting of cation-chloride cotransporters in neonatal seizures, Epilepsia, 2014, 55, 6
  10. 10
    D. R. Alessi, J. Zhang, A. Khanna, T. Hochdorfer, Y. Shang, K. T. Kahle, The WNK-SPAK/OSR1 pathway: Master regulator of cation-chloride cotransporters, Science Signaling, 2014, 7, 334, re3

    CrossRef

  11. 11
    Martha E. O’Donnell, Pharmacology of the Blood Brain Barrier: Targeting CNS Disorders, 2014,

    CrossRef